Inhibitory IgG receptor FcγRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis

  • Jing Li
  • , Erdem Tüzün
  • , Xiong Rong Wu
  • , Hui Bin Qi
  • , Windy Allman
  • , Shamsher S. Saini
  • , Premkumar Christadoss

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Deficiency of the inhibitory FcγRIIB renders mice susceptible to autoimmune disorders characterized with cellular infiltration of target tissue. To analyze the role of FcγRIIB in an antibody-mediated autoimmune disease, experimental autoimmune myasthenia gravis (EAMG), FcγRIIB knockout (KO) and wild-type mice were immunized with acetylcholine receptor (AChR). In contrast with previous reports, FcγRIIB KO mice were mildly resistant to EAMG despite preserved anti-AChR antibody production and neuromuscular junction complement deposition capacity. EAMG resistance was associated with reduced lymph node cell IL-6 and IL-10 production and increased CD4+CD25+ cell ratios in lymph nodes. Our data suggest that FcγRIIB promotes antibody-mediated autoimmunity.

Original languageEnglish (US)
Pages (from-to)44-53
Number of pages10
JournalJournal of Neuroimmunology
Volume194
Issue number1-2
DOIs
StatePublished - Feb 2008
Externally publishedYes

Keywords

  • Autoimmunity
  • FcγRIIB
  • IL-10
  • IL-6
  • Myasthenia gravis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Inhibitory IgG receptor FcγRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis'. Together they form a unique fingerprint.

Cite this